Tests tumor samples to help doctors pick cancer treatments.
No change
Duquesne owns 1.9 million shares of Caris Life Sciences, worth about $34 million. That’s less than $1 of every $100 they have in stocks. They didn’t really buy or sell any between April and June.
Mar 31
1,894,450
Jun 30
1,894,450
The numbers
Shares they own
1,894,450
Value on Jun 30, 2026
$33,759,000
about $34 million
Share of their money
0.8%
less than $1 of every $100 · 28th of 85
Price per share on Jun 30
$17.82
Kind
Shares
More about Caris Life Sciences ›
The value uses the price on Jun 30, 2026. The fund may have paid a different price.